4 February 2022 On World Cancer Day, EASL focusses on the global threat of liver cancer and we draw attention to our goals and efforts so far, embedded in our policy and…

25 January 2022 It is with great pleasure that EASL announces that their first open-access journal JHEP Reports has been accepted into Clarivate’s Science Citation Index Expanded (SCIE) and Journal Citation Reports.…

A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and metabolic-associated fatty liver disease (MAFLD), report scientists in the Journal of Hepatology. Amsterdam, December 6, 2021…

The EASL–Lancet Liver Commission calls for a paradigm shift in the liver disease response in Europe: prevention and early detection, not end-stage treatment of complications. Liver disease is now the second leading…

ClarivateTM Analytics released the 2021 update of its Journal Citation Reports©, including the much anticipated 2020 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology, achieved unprecedented results with a 2020…

For Immediate Release Media Release Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021 New data released on trials involving RNAi therapeutics, antivirals and structurally engineered fatty acids to…